On November 10, 2025, something extraordinary happened in women’s health.
After more than two decades of fear-based medicine, the FDA announced it is removing the broad black box warning from hormone replacement therapy (HRT) used for menopause. This isn’t a small regulatory tweak. This is a long-overdue course correction—and frankly, an apology written in scientific ink.
If you’re a woman navigating perimenopause or menopause (or supporting one), this decision matters deeply. And if you’ve ever been told, “Hormones are dangerous or that they cause cancer—just suffer through it,” this moment is for you.
Check out this video of the one and only, Dr. Mary Claire Haver, as she summarizes what this means. And for those of is who learn by both audio and visual learning, here’s a break down of what this actually means—and what every woman deserves to know.
First, Let’s Be Clear: This Is a Huge Win for Women
For years, women were denied safe, effective, life-changing treatment because of misinterpreted data and outdated science. The original black box warning stemmed from a Women’s Health Initiative study in the early 2000s that:
-
Studied women with an average age of 63 (well past the typical menopause transition)
-
Used a hormone formulation no longer commonly prescribed (Conjugated Equine Estrogens, made from pregnant horse urine!)
-
Showed a statistically non-significant increase in breast cancer risk—yet sparked widespread panic
The result? Hormone therapy use instantly plummeted . Millions of women were left untreated, undertreated, or flat-out dismissed and gaslit.
Fast forward to today: after a comprehensive review of decades of data, expert panels, and public comment, the FDA is restoring what should have always been front and center—evidence-based medicine.
As FDA Commissioner Dr. Marty Makary stated plainly:“Women and their physicians should make decisions based on data, not fear.”
Exactly.
The Top 5 Things Every Woman Needs to Know
1. The Black Box Warning Was Never the Full Story
The FDA is removing warnings related to breast cancer, cardiovascular disease, and probable dementia for menopausal hormone therapy. Why? Because modern research does not support the sweeping risks that were implied for most women.
Important nuance: the boxed warning for endometrial cancer remains for systemic estrogen-only therapy in women with a uterus—this is appropriate, evidence-based, and manageable with proper progesterone use.
This isn’t reckless medicine. It’s accurate medicine.
2. Timing Matters—And It Always Has
Here’s what the science has been telling us for years:
Women who start HRT within 10 years of menopause onset or before age 60 experience:
-
Reduced all-cause mortality (think about overall health)
-
Up to 50% lower cardiovascular risk (think heart health)
-
35% lower risk of Alzheimer’s disease (think brain health)
-
50–60% reduction in fractures (think bone health)
Hormones are not a one-size-fits-all solution—but timing, formulation, and individualized care make all the difference.
3. Estrogen Is Not the Enemy—It’s Essential
Let’s say this louder for the women who are still questioning the importance of Estrogen:
Estrogen is foundational to women’s health!
It affects:
-
Brain function and cognition
-
Bone density
-
Heart and vascular health
-
Muscle mass
-
Sleep, mood, and metabolic function
When estrogen declines, everything feels harder—because biologically, it is.
As Dr. Alicia Jackson from ARPA-H put it:“Every single part of a woman’s body depends on estrogen to operate at its best.”
This FDA decision finally reflects that reality.
4. Women Now Have More Options—Hormonal and Non-Hormonal
In addition to removing the black box warning, the FDA approved:
-
A generic version of Premarin, improving affordability and access
-
A new non-hormonal treatment for moderate to severe hot flashes for women who cannot or choose not to use hormones
This matters because real empowerment is about choice, not pressure.
5. This Decision Restores Autonomy—Not Mandates Treatment
Let me be crystal clear:
This does not mean every woman should take hormone therapy.
It means women can finally:
-
Have informed, unbiased conversations
-
Weigh benefits and risks accurately
-
Decide what’s right for their body, values, and health history
That’s not radical. That’s responsible healthcare.
Why This Matters So Much (And Why I’m Talking About It)
For too long, women were told menopause was something to “just get through.” No solutions. No options. No nuance.
This FDA decision is a signal shift—from silence and suffering to science and support.
As a women’s health expert, coach, and advocate, my role is to help women:
-
Understand their options
-
Ask better questions
-
Advocate for themselves
-
Build a comprehensive plan that includes lifestyle, mindset, movement, nutrition and medical care
Perimenopause (8-10 years of our lives) and Post-Menopause (30+ years) is not the end of vitality—it’s a transition. And transitions deserve support and options, not fear.
The Bottom Line
The black box is gone. The data is clear. The conversation has changed.
And finally—women are being trusted with the truth.
If you’re navigating this season of life and wondering what your next step should be, know this: you are not broken, you are not “crazy”, you don’t have to suck it up and get through it and you are not alone!” You are responding to biology—and now, the science finally has your back. This is what it means to be inspired by living well.
